Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Rang in Aktien #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Aktienkurs
$0.85814713
Zuletzt synchronisiert: 2025-05-14
Marktkapitalisierung
$463.40M
Veränderung (1 Tag)
-2.52%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Alliance Pharma plc (APH)

Kategorie

EPS für Alliance Pharma plc (APH)
EPS zum December 2024 TTM: $-0.03
Laut den aktuellen Finanzberichten und dem Aktienkurs von Alliance Pharma plc beträgt das aktuelle EPS des Unternehmens (TTM) $-0.03. Am Ende des Jahres 2023 betrug das EPS $-0.08 ein Rückgang im Vergleich zu dem EPS von 2022, das $0.00 betrug.
EPS-Verlauf von Alliance Pharma plc von 2001 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.03 -16.67%
2024 $-0.03 -67.95%
2023 $-0.08 -3,814.29%
2022 0.00 -88.65%
2021 $0.02 -12.32%
2020 $0.02 -66.88%
2019 $0.06 35.53%
2018 $0.05 -42.96%
2017 $0.08 73.47%
2016 $0.05 -30.66%
2015 $0.07 38.66%
2014 $0.05 -21.96%
2013 $0.06 8.02%
2012 $0.06 4.27%
2011 $0.06 -8.77%
2010 $0.06 60.42%
2009 $0.04 69.91%
2008 $0.02 -157.22%
2007 $-0.04 -726.98%
2006 $0.01 -18.18%
2005 $0.01 -116.96%
2004 $-0.05 109.22%
2002 $-0.02 -401.39%
2001 $0.01 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber